Exploring barriers to Pirfenidone adherence in patients with idiopathic pulmonary fibrosis: a prospective study
A. Delameillieure (Leuven, Belgium), F. Dobbels (Leuven, Belgium), K. Leceuvre (Leuven, Belgium), D. Strens (Leuven, Belgium), P. Simaels (Leuven, Belgium), K. Verheyen (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), W. Wuyts (Leuven, Belgium)
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Delameillieure (Leuven, Belgium), F. Dobbels (Leuven, Belgium), K. Leceuvre (Leuven, Belgium), D. Strens (Leuven, Belgium), P. Simaels (Leuven, Belgium), K. Verheyen (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), W. Wuyts (Leuven, Belgium). Exploring barriers to Pirfenidone adherence in patients with idiopathic pulmonary fibrosis: a prospective study. 1816
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: